TY  - CHAP
AU  - S. L. M. van Loon
AU  - A. I. P. M. Smits
AU  - A. Driessen-Mol
AU  - F. P. T. Baaijens
and C. V. C. Bouten
ED  - Elena Aikawa
Y1  - 2013-06-12
PY  - 2013
T1  - The Immune Response in In Situ Tissue Engineering of Aortic Heart Valves
N2  - Due to population aging, calcific aortic valve disease (CAVD) has become the most common heart valve disease in Western countries. No therapies exist to slow this disease progression, and surgical valve replacement is the only effective treatment. Calcific Aortic Valve Disease covers the contemporary understanding of basic valve biology and the mechanisms of CAVD, provides novel insights into the genetics, proteomics, and metabolomics of CAVD, depicts new strategies in heart valve tissue engineering and regenerative medicine, and explores current treatment approaches. As we are on the verge of understanding the mechanisms of CAVD, we hope that this book will enable readers to comprehend our current knowledge and focus on the possibility of preventing disease progression in the future.
BT  - Calcific Aortic Valve Disease
SP  - Ch. 8
UR  - https://doi.org/10.5772/54354
DO  - 10.5772/54354
SN  - 
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-19
ER  -